Sangamo Therapeutics (GBY.F) Q1 2025 Earnings

17MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.25
-0.15
-0.06
0.04

Details

Expected EPS
-0.0835631
Actual EPS
-0.1007336
Surprise EPS
-0.02
Surprise Percent
+20.55%

Description

Sangamo Therapeutics (GBY.F) has reported earnings of -0.1007336 per share for Q1 2025.

0 Comments

Share your thoughts